Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials

BACKGROUND: Peripheral blood parameters are correlated to immune‐checkpoint inhibitor efficacy in solid tumors, such as melanoma and non‐small cell lung cancer. Few data are currently available on the prognostic role of these immune‐inflammatory biomarkers for other solid tumors and immunotherapy co...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Criscitiello, Carmen, Marra, Antonio, Morganti, Stefania, Zagami, Paola, Viale, Giulia, Esposito, Angela, Curigliano, Giuseppe
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Immuno‐Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648370/
https://ncbi.nlm.nih.gov/pubmed/32785940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0518
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki